Application and exploration of ultrasound-guided nerve block technology in multimodal analgesia for ICU patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300075099

Enrollment

Unknown

Registered

2023-08-24

Start date

2020-02-03

Completion date

Unknown

Last updated

2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU patients with pain

Interventions

Control group:Use conventional intravenous continuous infusion of opioid analgesics for analgesia (sufentanil 0.1-0.3ug/kg/h or fentanyl 0.5-2ug/kg/h)

Nerve block group:After standard skin disinfection, After negative aspiration for blood, 5 ml of 0.5% ropivacaine was slowly injected in the form of single shot in every target position and it was rep

Eligibility

Sex/Gender

All

Age

20 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? = 18 years old; ? The expected hospitalization time in the ICU exceeds 3 days; ? Patients in need of pain relief

Exclusion criteria

Exclusion criteria: ? The puncture site is infected with Analgesic or local anesthesia Drug allergy; ? Alcohol abuse, severe liver dysfunction (Child-Push C-grade); ? Suffering from primary neuromuscular diseases; ? Pregnancy or lactation; ? Obesity (body mass index>35); ? Cardiovascular instability; ? Participated in other clinical trials

Design outcomes

Primary

Measure	Time frame
VAS score (resting, active);	—

Secondary

Measure	Time frame
Vital signs (blood pressure, heart rate);Respiratory oxygenation (ventilator parameters, PaO2/FiO2);	—

Countries

China

Contacts

Public ContactXiaofeng Ou

West China Hospital, Sichuan University

xiao.ou2006@163.com+86 189 8060 5531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026